Device Trial Radar · NCT03791970
Stents Post-dilation With DCB or POBA in Femoropopliteal Arteries
Last checked: Nov 20, 2026Latest source record: May 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
180
Planned (sponsor's estimate)
Start
Jan 1, 2019
Primary completion
Dec 31, 2026
Study completion Dec 31, 2026
Sponsor
- Lead sponsor
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 3, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To compare the efficacy and safety of stent angioplasty with Orchid 035 Drug Coated Dilatation (DCB) and Plain Old Balloon Angioplasty (POBA) for post-dilatation for long (\>10cm) femoropopliteal chronic total occlusion.
Conditions
- Peripheral Artery Disease
Interventions
Orchid 035 DCB CatheterDevice
Stents placement for femoropopliteal arterial occlusions following with Orchid 035 DCB Catheter for post-dilation
POBA CatheterDevice
Stents placement for femoropopliteal arterial occlusions following with POBA for post-dilation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary patency rateTime frame: 12 months post-procedure
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Kaichuang Ye
Shanghai, Shanghai Municipality, China · Recruiting
Minyi Yin
Shanghai, Shanghai Municipality, China · Recruiting
Xiaobing Liu
Shanghai, Shanghai Municipality, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.